Cleared Traditional

K221343 - ECHELON ENDOPATH Staple Line Reinforcement (FDA 510(k) Clearance)

Sep 2022
Decision
130d
Days
Class 2
Risk

K221343 is an FDA 510(k) clearance for the ECHELON ENDOPATH Staple Line Reinforcement. This device is classified as a Mesh, Surgical, Absorbable, Staple Line Reinforcement (Class II - Special Controls, product code OXC).

Submitted by Ethicon Endo-Surgery, LLC (Guaynabo, US). The FDA issued a Cleared decision on September 16, 2022, 130 days after receiving the submission on May 9, 2022.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.3300. For Reinforcement Of Soft Tissue Where Weakness Exists During Staple Line Reinforcement Procedures..

Submission Details

510(k) Number K221343 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 09, 2022
Decision Date September 16, 2022
Days to Decision 130 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code OXC — Mesh, Surgical, Absorbable, Staple Line Reinforcement
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.3300
Definition For Reinforcement Of Soft Tissue Where Weakness Exists During Staple Line Reinforcement Procedures.